Video: Lamellar's McLean Talks R&D plans and early-stage CF therapy
This article was originally published in Scrip
Executive Summary
Mike Ward, global director of content for Informa Pharma Insights, chats to Lamellar Biomedical ltd.'s CEO Dr. Alec McLean at the recent BIO-Europe partnering meeting in Munich, Germany, about the firm's R&D plans for recently raised funds and progress of Lamellar's cystic fibrosis program.